Reminder Tool for Liver Cancer Screening Ultrasounds in Patients With Cirrhosis
Tests a computer prompt that reminds staff to order liver ultrasounds in adults with cirrhosis.
Key facts
- Who runs it
- NYU Langone Health
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
- Status
- Enrolling by invitation
- People taking part
- 1,300 people, planned
- Started
- 20 Nov 2024
- Planned end
- 24 Jul 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Auto-pended bot liver ultrasound order
- Record updated
- 27 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with cirrhosis who had their last liver imaging 6 months ago or more. It tests a prompt that helps doctors order liver cancer screening.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Cirrhosis diagnosis
- Earlier treatment
- Last imaging was 6 months or more ago. No previous liver transplant.
Main reasons for not taking part
- Previous liver transplant
- Diagnosis of hepatocellular carcinoma (HCC)
- Receiving hospice care
- Had outside imaging in the past 6 months
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- cirrhosis diagnosis,
- 6 months or more after since most recent imaging
Who cannot take part
- previous liver transplant,
- receiving hospice care,
- HCC diagnosis,
- completed external imaging in the past 6 months
Where in United States
- NYU Langone HealthNew York, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The research team will evaluate the effectiveness of an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.
The 2 groups in the trial
- Intervention: Auto-pended bot liver ultrasound order
Participants in the intervention group will receive an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening.
Treatment: Auto-pended bot liver ultrasound order
- Control: Usual Care
Participants in the control group will not receive the auto-pended bot liver ultrasound order.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Active Choice Clinical Decision Support: Hepatocellular Carcinoma Screening in Patients With Cirrhosis
- Plain-language title
- Reminder Tool for Liver Cancer Screening Ultrasounds in Patients With CirrhosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 27 February 2026